All lobbying filings

W STRATEGIES, LLC

Lobbying for ABBOTT LABORATORIES · A pharmaceuticals health care company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income · posted Apr 20, 2026

Official filing document

Bills named in this filing 1

HR 2300
To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other pu…

Lobbying activity 1

Health Issues

Issues related to infant formula access. H.R.2300 - To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.